Press releases
Access archived Guidant press releases
Access archived BTG press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Oct 25, 2006Positive results also reported for TAXUS Liberte stent direct stenting
Boston Scientific Corporation (NYSE: BSX) today announced 12-month follow-up data from TAXUS ATLAS, the pivotal clinical trial...
-
Oct 25, 2006
Boston Scientific Corporation (NYSE: BSX) today announced positive results from its global TAXUS OLYMPIA registry, supporting the...
-
Oct 23, 2006Results also show statistically significant late stent thrombosis rate for Cypher® stent vs. bare-metal stent
Boston Scientific Corporation (NYSE: BSX) today announced that an independent meta-analysis of more than 3,500 patients from five...
-
Oct 23, 2006Two-year results continue to evaluate long-term safety and efficacy
Boston Scientific (NYSE: BSX) today announced two-year data from its BEACH carotid artery stenting (CAS) clinical trial. The study...
-
Oct 23, 2006Multi-center registry to enroll 10,000 patients over two years
Boston Scientific Corporation (NYSE: BSX) today announced that it intends to provide lead financial support for an extension of the...
-
Oct 22, 2006
Boston Scientific Corporation (NYSE: BSX) today announced one-year results from its TC-WYRE (TAXUS® Express2™ Stent vs. Cypher Stent: What's...
-
Oct 18, 2006
Boston Scientific Corporation (NYSE: BSX) today announced financial results for the third quarter ended September 30, 2006. Net sales for the third...
-
Oct 18, 2006Results to include new data on next-generation TAXUS® Liberte™ Stent System
Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and press announcements at the Cardiovascular...
-
Oct 16, 2006
Boston Scientific Corporation (NYSE: BSX) today announced the initiation of a new clinical trial designed to identify and investigate clinically...
-
Oct 16, 2006PROMUS stent to complement Company's market-leading TAXUS® stent systems
Boston Scientific Corporation (NYSE: BSX) announced today that the PROMUS™ Everolimus-Eluting Coronary Stent System has received CE Mark...
-
Oct 12, 2006
Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Court of Appeals for the Federal Circuit has affirmed the validity of a key...
-
Oct 4, 2006
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the third quarter ended September 30,...
-
Oct 2, 2006FDA approval makes remote monitoring available by more than 150,000 additional patients
Boston Scientific Corporation (NYSE: BSX) today announced a U.S. Food and Drug Administration (FDA) approval that permits the LATITUDE® Patient...
-
Sep 29, 2006Gobierno de Puerto Rico aprueba el Sistema Precision, que brinda a los médicos una nueva opción de tratamiento para dolor agudo y crónico
Boston Scientific Corporation (NYSE: BSX) anunció hoy sobre el primer paciente implantado en Puerto Rico con el Precision Spinal Cord Stimulation...
-
Sep 28, 2006
Boston Scientific Corporation (NYSE: BSX) today announced that it plans to adopt the recommendations announced today by the Heart Rhythm Society...
-
Sep 27, 2006
Boston Scientific Corporation (NYSE: BSX) today announced the approval of its new Harmony™ HiResolution® Bionic Ear System (Harmony System) by...
-
Sep 26, 2006CryoPlasty® Therapy may be an alternative to surgery or limb amputation
Boston Scientific Corporation (NYSE: BSX) today announced excellent six-month results from its Below-The-Knee (BTK) CHILL trial. This study, a...
-
Sep 21, 2006
Boston Scientific Corporation (NYSE: BSX) today announced preliminary net sales and earnings for its third quarter ending September 30, 2006....
-
Sep 19, 2006FLEXView™ System enables physicians to perform less-invasive cardiac surgical ablation procedures
Boston Scientific Corporation (NYSE: BSX) today announced the U.S. market launch of the FLEXView™ System for unilateral visualization and...
-
Sep 14, 2006
Boston Scientific Corporation (NYSE: BSX) today issued the following comment on the statement of the U.S. Food and Drug Administration on...
-
Sep 13, 2006
Boston Scientific Corporation (NYSE: BSX) today welcomed the results of two studies and an editorial published in today's edition of The New...
-
Sep 6, 2006Overall cardiac death rate for combined bare-metal control group equivalent to TAXUS slow- and moderate-release formulations
Boston Scientific Corporation (NYSE: BSX) today announced four-year follow-up data from its TAXUS II paclitaxel-eluting stent system...
-
Sep 5, 2006Initial six-month results show positive outcomes in diabetic patients; safety events for diabetic subset lower than overall patient population
Boston Scientific Corporation (NYSE: BSX) today announced six-month results from Phase I of its global TAXUS OLYMPIA registry,...
-
Sep 5, 2006International data suggests low revascularization rates for both TAXUS stent and PROMUS™ (XIENCE™ V) stent
Boston Scientific Corporation (NYSE: BSX) today welcomed the results of Abbott's SPIRIT II clinical trial, which reaffirmed...
-
Sep 1, 2006PROMUS Stent joins market-leading TAXUS® Paclitaxel-Eluting Coronary Stent Systems
Boston Scientific Corporation (NYSE: BSX) today announced plans for the anticipated International launch of its PROMUS™(1) Everolimus-Eluting...
-
Aug 31, 2006Results expected to continue to support safety and performance of Boston Scientific's second-generation drug-eluting stent system
Boston Scientific Corporation (NYSE: BSX) announced today that enrollment has exceeded 13,000 patients in the TAXUS OLYMPIA registry, designed to...
-
Aug 30, 2006
Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and press announcements at the European...
-
Aug 23, 2006
ACME, Inc. has named Charlie Young senior vice president of marketing. Young comes to the company with more than 18 years of marketing experience. Young will oversee and direct the company's...
-
Jul 27, 2006
Boston Scientific Corporation (NYSE: BSX) today announced financial results for the second quarter ended June 30, 2006. Highlights: - Acquisition...
-
Jul 26, 2006Precision™ SCS System, the first and smallest rechargeable system, achieves rapid adoption
Boston Scientific Corporation (NYSE: BSX) announced today that 5,000 patients with severe chronic pain have now been treated with the Precision™...
-
Jul 24, 2006Initial six-month results consistent with previous TAXUS registries
Boston Scientific Corporation (NYSE: BSX) today announced preliminary six-month results from Phase I of its global...
-
Jul 14, 2006New system enhances diagnosis and treatment of blocked vessels and heart disorders
Boston Scientific Corporation (NYSE: BSX) today announced the U.S. launch of its iLab™ Ultrasound Imaging System. Intravascular ultrasound (IVUS)...
-
Jul 12, 2006New Jaw Configuration Designed to Yield Larger Tissue Specimens and Improve Procedural Outcomes
Boston Scientific Corporation (NYSE: BSX) today announced the U.S. launch of the newest version of its Radial Jaw® Single-Use Biopsy Forceps,...
-
Jul 10, 2006
Boston Scientific Corporation (NYSE: BSX) today announced that William E. Young has been appointed Vice President of Quality Assurance and...
-
Jul 10, 2006
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the second quarter ended June 30, 2006...
-
Jun 28, 2006
Boston Scientific Corporation (NYSE: BSX) today welcomed the results of a report from UBS Investment Research that ranked the Company number one in...
-
Jun 26, 2006
Boston Scientific Corporation (NYSE: BSX) today announced that it is providing safety information and retrieving a specific subset of pacemakers,...
-
Jun 23, 2006
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Jefferies Life Sciences Conference, which is being held June 27 - 28...
-
Jun 15, 2006
Boston Scientific Corporation (NYSE: BSX) announced that the U.S. District Court in Delaware issued a ruling upholding a July 2005 jury verdict in...
-
Jun 12, 2006Boston Scientific's TAXUS stent system used in more complex lesions than J&J's Cypher
Boston Scientific Corporation (NYSE: BSX) welcomed results from the independent, multi-center STENT registry, the largest prospective, comparative...
-
Jun 9, 2006
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in Goldman Sachs' 25th Annual Healthcare Conference, which is being held June...
-
Jun 9, 2006
Boston Scientific Corporation (NYSE: BSX) announced today the completion of a public offering of $1.2 billion aggregate principal amount of its...
-
Jun 6, 2006
Boston Scientific Corporation (NYSE: BSX) announced today the pricing of a public offering of $1.2 billion aggregate principal amount of its senior...
-
Jun 6, 2006Technology Features Powerful Combination of Deliverability and Trackability to Enhance Clinical Versatility
Boston Scientific Corporation (NYSE: BSX) today announced that it has received FDA clearance to launch its Sterling™ Monorail® and Over-the-Wire...
-
May 31, 2006
Boston Scientific Corporation (NYSE: BSX) today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market...
-
May 26, 2006
Boston Scientific Corporation (NYSE: BSX) announced today that the Court of Appeals for the Federal Circuit has issued a ruling upholding a trial...
-
May 22, 2006Researchers say novel visualization capability may reduce common need for repeat procedures
Boston Scientific Corporation (NYSE: BSX) today announced favorable results from an investigator initiated first human use...
-
May 20, 2006Trial Advances Understanding of Dual-chamber Pacing for Patients at Risk of Sudden Cardiac Death
Boston Scientific Corporation (NYSE: BSX) today reported that the INTRINSIC RV investigative team presented results of a clinical trial designed to...
-
May 19, 2006LATITUDE® Patient Management System Aligns Closely with Recent ACC/AHA Guidelines on Managing Heart Failure
Boston Scientific Corporation (NYSE: BSX) today announced the launch of two large-scale clinical studies to evaluate the benefits of the LATITUDE®...
-
May 18, 2006Physician Society Draft Recommendations Reinforce LATITUDE Active Monitoring ™ Capabilities
Boston Scientific Corporation (NYSE: BSX) today announced the one-year anniversary of the company's first implant of the CONTAK RENEWAL® RF family...